“Conventional chest tubes are prone to clogging, which can hinder recovery,” one researcher explained. 

When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.

Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

Where a cautious President Biden wanted to confine American AI know-how to America, a freewheeling President Trump wants to turn it loose—at least to select friends and allies.

These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain.

New data out of Sweden show that using Abbott's continuous glucose monitor technology is associated with a reduced risk of being hospitalized for cardiac complications. This was true for patients with and without a history of prior heart disease.

For some, the FDA is moving too fast in its drive to adopt generative AI agency-wide.